303 related articles for article (PubMed ID: 14633816)
1. Benefits and risks of solitary islet transplantation for type 1 diabetes using steroid-sparing immunosuppression: the National Institutes of Health experience.
Hirshberg B; Rother KI; Digon BJ; Lee J; Gaglia JL; Hines K; Read EJ; Chang R; Wood BJ; Harlan DM
Diabetes Care; 2003 Dec; 26(12):3288-95. PubMed ID: 14633816
[TBL] [Abstract][Full Text] [Related]
2. Clinical islet transplantation in type 1 diabetes mellitus: results of Australia's first trial.
O'Connell PJ; Hawthorne WJ; Holmes-Walker DJ; Nankivell BJ; Gunton JE; Patel AT; Walters SN; Pleass HC; Allen RD; Chapman JR
Med J Aust; 2006 Mar; 184(5):221-5. PubMed ID: 16515432
[TBL] [Abstract][Full Text] [Related]
3. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen.
Shapiro AM; Lakey JR; Ryan EA; Korbutt GS; Toth E; Warnock GL; Kneteman NM; Rajotte RV
N Engl J Med; 2000 Jul; 343(4):230-8. PubMed ID: 10911004
[TBL] [Abstract][Full Text] [Related]
4. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience.
Froud T; Ricordi C; Baidal DA; Hafiz MM; Ponte G; Cure P; Pileggi A; Poggioli R; Ichii H; Khan A; Ferreira JV; Pugliese A; Esquenazi VV; Kenyon NS; Alejandro R
Am J Transplant; 2005 Aug; 5(8):2037-46. PubMed ID: 15996257
[TBL] [Abstract][Full Text] [Related]
5. Sequential kidney/islet transplantation: efficacy and safety assessment of a steroid-free immunosuppression protocol.
Toso C; Baertschiger R; Morel P; Bosco D; Armanet M; Wojtusciszyn A; Badet L; Philippe J; Becker CD; Hadaya K; Majno P; Bühler L; Berney T;
Am J Transplant; 2006 May; 6(5 Pt 1):1049-58. PubMed ID: 16611343
[TBL] [Abstract][Full Text] [Related]
6. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center.
Goss JA; Schock AP; Brunicardi FC; Goodpastor SE; Garber AJ; Soltes G; Barth M; Froud T; Alejandro R; Ricordi C
Transplantation; 2002 Dec; 74(12):1761-6. PubMed ID: 12499894
[TBL] [Abstract][Full Text] [Related]
7. Achievement of insulin independence via pancreatic islet transplantation using a remote isolation center: a first-year review.
Barshes NR; Lee T; Goodpasture S; Brunicardi FC; Alejandro R; Ricordi C; Soltes G; Barth M; Hamilton D; Goss JA
Transplant Proc; 2004 May; 36(4):1127-9. PubMed ID: 15194393
[TBL] [Abstract][Full Text] [Related]
8. Islet of Langerhans allogeneic transplantation at the University of Geneva in the steroid free era in islet after kidney and simultaneous islet-kidney transplantations.
Berney T; Bucher P; Mathe Z; Andres A; Bosco D; Mage R; Toso C; Oberholzer J; Becker C; Philippe J; Bühler L; Morel P
Transplant Proc; 2004 May; 36(4):1121-2. PubMed ID: 15194390
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous islet and kidney transplantation in seven patients with type 1 diabetes and end-stage renal disease using a glucocorticoid-free immunosuppressive regimen with alemtuzumab induction.
Tan J; Yang S; Cai J; Guo J; Huang L; Wu Z; Chen J; Liao L
Diabetes; 2008 Oct; 57(10):2666-71. PubMed ID: 18633105
[TBL] [Abstract][Full Text] [Related]
10. Experience with a novel efalizumab-based immunosuppressive regimen to facilitate single donor islet cell transplantation.
Turgeon NA; Avila JG; Cano JA; Hutchinson JJ; Badell IR; Page AJ; Adams AB; Sears MH; Bowen PH; Kirk AD; Pearson TC; Larsen CP
Am J Transplant; 2010 Sep; 10(9):2082-91. PubMed ID: 20883542
[TBL] [Abstract][Full Text] [Related]
11. Successful islet transplantation for patients with diabetes--fact or fantasy?
Robertson RP
N Engl J Med; 2000 Jul; 343(4):289-90. PubMed ID: 10911012
[No Abstract] [Full Text] [Related]
12. Successful simultaneous islet-kidney transplantation using a steroid-free immunosuppression: two-year follow-up.
Lehmann R; Weber M; Berthold P; Züllig R; Pfammatter T; Moritz W; Mädler K; Donath M; Ambühl P; Demartines N; Clavien And PA; Andreia Spinas G
Am J Transplant; 2004 Jul; 4(7):1117-23. PubMed ID: 15196070
[TBL] [Abstract][Full Text] [Related]
13. Relevance of cytotoxic alloreactivity under different immunosuppressive regimens in clinical islet cell transplantation.
Roelen DL; Huurman VA; Hilbrands R; Gillard P; Duinkerken G; van der Meer-Prins PW; Versteeg-van der Voort Maarschalk MF; Mathieu C; Keymeulen B; Pipeleers DG; Roep BO; Claas FH
Clin Exp Immunol; 2009 Apr; 156(1):141-8. PubMed ID: 19161445
[TBL] [Abstract][Full Text] [Related]
14. Histopathological study of intrahepatic islets transplanted in the nonhuman primate model using edmonton protocol immunosuppression.
Hirshberg B; Mog S; Patterson N; Leconte J; Harlan DM
J Clin Endocrinol Metab; 2002 Dec; 87(12):5424-9. PubMed ID: 12466330
[TBL] [Abstract][Full Text] [Related]
15. Islet transplantation with alemtuzumab induction and calcineurin-free maintenance immunosuppression results in improved short- and long-term outcomes.
Froud T; Baidal DA; Faradji R; Cure P; Mineo D; Selvaggi G; Kenyon NS; Ricordi C; Alejandro R
Transplantation; 2008 Dec; 86(12):1695-701. PubMed ID: 19104407
[TBL] [Abstract][Full Text] [Related]
16. Improved metabolic control and quality of life in seven patients with type 1 diabetes following islet after kidney transplantation.
Cure P; Pileggi A; Froud T; Messinger S; Faradji RN; Baidal DA; Cardani R; Curry A; Poggioli R; Pugliese A; Betancourt A; Esquenazi V; Ciancio G; Selvaggi G; Burke GW; Ricordi C; Alejandro R
Transplantation; 2008 Mar; 85(6):801-12. PubMed ID: 18360260
[TBL] [Abstract][Full Text] [Related]
17. Kidney function after islet transplant alone in type 1 diabetes: impact of immunosuppressive therapy on progression of diabetic nephropathy.
Maffi P; Bertuzzi F; De Taddeo F; Magistretti P; Nano R; Fiorina P; Caumo A; Pozzi P; Socci C; Venturini M; del Maschio A; Secchi A
Diabetes Care; 2007 May; 30(5):1150-5. PubMed ID: 17259471
[TBL] [Abstract][Full Text] [Related]
18. Glycemic Stability Through Islet-After-Kidney Transplantation Using an Alemtuzumab-Based Induction Regimen and Long-Term Triple-Maintenance Immunosuppression.
Nijhoff MF; Engelse MA; Dubbeld J; Braat AE; Ringers J; Roelen DL; van Erkel AR; Spijker HS; Bouwsma H; van der Boog PJ; de Fijter JW; Rabelink TJ; de Koning EJ
Am J Transplant; 2016 Jan; 16(1):246-53. PubMed ID: 26288226
[TBL] [Abstract][Full Text] [Related]
19. [Focus on Islets of Langerhans transplantation].
Bayle F
Presse Med; 2001 Sep; 30(24 Pt 2):19-20. PubMed ID: 11577579
[TBL] [Abstract][Full Text] [Related]
20. Comparison of sirolimus alone with sirolimus plus tacrolimus in type 1 diabetic recipients of cultured islet cell grafts.
Gillard P; Ling Z; Mathieu C; Crenier L; Lannoo M; Maes B; Roep B; Gorus F; Pipeleers D; Keymeulen B
Transplantation; 2008 Jan; 85(2):256-63. PubMed ID: 18212631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
